Completed NA INTERVENTIONAL NCT00512226

Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia

Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia Using T2* Cardiac MRI.

Sponsor: HaEmek Medical Center, Israel

Conditions Iron Overload MRI Sickle Cell Anemia Sickle Cell Thalassemia

Interventions Cardiac and Liver T2* MRI

Updated 5 times since 2017 Last updated: Aug 25, 2011 Started: Sep 30, 2007 Primary completion: Dec 31, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Iron Overload and MRI and is currently completed. HaEmek Medical Center, Israel leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

HaEmek Medical Center, Israel
Wolfson Medical Center

Data source: HaEmek Medical Center, Israel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Afula, Israel